These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38983018)

  • 1. Case Report: Scleral hyperpigmentation associated with oral hydroxychloroquine use.
    Maretz C; Omoruyi F; Wozniak RAF
    Front Ophthalmol (Lausanne); 2023; 3():1192019. PubMed ID: 38983018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline-induced blue sclera and skin hyperpigmentation.
    Law S
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34794979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine-induced hyperpigmentation of the skin and bull's-eye maculopathy in rheumatic patients: a case report and literature review.
    Peng JP; Yang XY; Luo F; Yuan XM; Xiong H; Ma WK; Yao XM
    Front Immunol; 2024; 15():1383343. PubMed ID: 38660312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation.
    Morrison LK; Nordlund JJ; Heffernan MP
    Dermatol Online J; 2009 Dec; 15(12):15. PubMed ID: 20040265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline-Induced Scleral and Dermal Hyperpigmentation.
    Haskes C; Shea M; Imondi D
    Optom Vis Sci; 2017 Mar; 94(3):436-442. PubMed ID: 27870777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline-Induced Ocular Ochronosis.
    Baaklini C; Kesav N; Reinhart W
    Cureus; 2023 Aug; 15(8):e43307. PubMed ID: 37700983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
    Leung AK; McMillan T; Human A; Lam JM
    Drugs Context; 2020; 9():. PubMed ID: 32742294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blue Skin, Nail, and Scleral Pigmentation Associated with Minocycline.
    Ricardo JW; Shah K; Minkis K; Lipner SR
    Case Rep Dermatol; 2022; 14(2):239-242. PubMed ID: 36158857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrochloroquine retinopathy: characteristic presentation with review of screening.
    Stelton CR; Connors DB; Walia SS; Walia HS
    Clin Rheumatol; 2013 Jun; 32(6):895-8. PubMed ID: 23515601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine-induced pigmentation in rheumatic diseases: prevalence, clinical features and influencing factors.
    Yin ZJ; Li P; Yu J; Zuo D; Fan H; Li F; Wang J; Gao F; Zhao W; Wang S; Ma S; Wang J
    Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38588566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
    Ahn SJ; Ryu SJ; Joung JY; Lee BR
    Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature.
    Paradisi A; Bugatti L; Sisto T; Filosa G; Amerio PL; Capizzi R
    Clin Ther; 2008 May; 30(5):930-40. PubMed ID: 18555940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial.
    Gheet FS; Dawoud HE; El-Shahaby WA; Elrifaey SM; Abdelnabi HH
    Eur J Pediatr; 2023 Apr; 182(4):1685-1695. PubMed ID: 36752895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
    Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H
    J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
    Ameen Ismail A; Sadek SH; Hatata RM
    BMC Ophthalmol; 2022 Nov; 22(1):434. PubMed ID: 36376841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
    Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
    Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleral Discoloration Because of Minocycline Use: A Case Report and Review of the Literature.
    F K Islam Y; P Horn E
    Mil Med; 2023 Mar; 188(3-4):e890-e893. PubMed ID: 34027971
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.